LogicBio Therapeutics

LogicBio Therapeutics

Develops gene therapy vectors for previously incurable genetic and infectious diseases including hemophilia, HIV/AIDS, and methylmalonic acidemia.

HQ location
Cambridge, United States
Founding location
Ness Ziona, Israel
Launch date
Employees
Market cap
$177m
Enterprise value
$28m
Share price
$6.81 LOGC
Authorizing premium user...